{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:44:52Z","timestamp":1790401492302,"version":"4.1.0"},"reference-count":78,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401636\/2013-5"],"award-info":[{"award-number":["401636\/2013-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1107597"],"award-info":[{"award-number":["OPP1107597"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,4,5]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the accuracy of metabolomics in predicting hypertensive disorders in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review of observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources and study eligibility criteria<\/jats:title>\n                    <jats:p>An electronic literature search was performed in June 2019 and February 2022. Two researchers independently selected studies published between 1998 and 2022 on metabolomic techniques applied to predict the condition; subsequently, they extracted data and performed quality assessment. Discrepancies were dealt with a third reviewer. The primary outcome was pre-eclampsia. Cohort or case\u2013control studies were eligible when maternal samples were taken before diagnosis of the hypertensive disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study appraisal and synthesis methods<\/jats:title>\n                    <jats:p>Data on study design, maternal characteristics, how hypertension was diagnosed, metabolomics details and metabolites, and accuracy were independently extracted by two authors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 4613 initially identified studies on metabolomics, 68 were read in full text and 32 articles were included. Studies were excluded due to duplicated data, study design or lack of identification of metabolites. Metabolomics was applied mainly in the second trimester; the most common technique was liquid-chromatography coupled to mass spectrometry. Among the 122 different metabolites found, there were 23 amino acids and 21 fatty acids. Most of the metabolites were involved with ammonia recycling; amino acid metabolism; arachidonic acid metabolism; lipid transport, metabolism and peroxidation; fatty acid metabolism; cell signalling; galactose metabolism; nucleotide sugars metabolism; lactose degradation; and glycerolipid metabolism. Only citrate was a common metabolite for prediction of early-onset and late-onset pre-eclampsia. Vitamin D was the only metabolite in common for pre-eclampsia and gestational hypertension prediction. Meta-analysis was not performed due to lack of appropriate standardised data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and implications<\/jats:title>\n                    <jats:p>Metabolite signatures may contribute to further insights into the pathogenesis of pre-eclampsia and support screening tests. Nevertheless, it is mandatory to validate such methods in larger studies with a heterogeneous population to ascertain the potential for their use in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42018097409.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054697","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:08:34Z","timestamp":1652774914000},"page":"e054697","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Prediction of pregnancy-related hypertensive disorders using metabolomics: a systematic review"],"prefix":"10.1136","volume":"12","author":[{"given":"Jussara","family":"Mayrink","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora F","family":"Leite","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-4256","authenticated-orcid":false,"given":"Guilherme M","family":"Nobrega","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1285-8445","authenticated-orcid":false,"given":"Jose Guilherme","family":"Cecatti","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"2025120518021172000_12.4.e054697.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00070-7"},{"key":"2025120518021172000_12.4.e054697.2","unstructured":"Taylor R , Roberts J , Cunningham F . Chesley\u2019s hypertensive disorders in pregnancy. 4th edn. Elsevier, 2015."},{"key":"2025120518021172000_12.4.e054697.3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14781"},{"key":"2025120518021172000_12.4.e054697.4","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3109\/14767058.2015.1113522","article-title":"Early serum markers of pre-eclampsia: are we stepping forward?","volume":"29","author":"Lagan\u00e0","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025120518021172000_12.4.e054697.5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/19396368.2018.1482968","article-title":"Application of metabolomics to preeclampsia diagnosis","volume":"64","author":"Nobakht M Gh","year":"2018","journal-title":"Syst Biol Reprod Med"},{"key":"2025120518021172000_12.4.e054697.6","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-012-0482-9"},{"key":"2025120518021172000_12.4.e054697.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2251"},{"key":"2025120518021172000_12.4.e054697.8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.ircmb.2019.07.003","article-title":"Application of metabolomics technologies toward cancer prognosis and therapy","volume":"347","author":"Hoang","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"2025120518021172000_12.4.e054697.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038832"},{"key":"2025120518021172000_12.4.e054697.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2025120518021172000_12.4.e054697.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.02.001"},{"key":"2025120518021172000_12.4.e054697.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2000.tb01136.x"},{"key":"2025120518021172000_12.4.e054697.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01747-1"},{"key":"2025120518021172000_12.4.e054697.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"2025120518021172000_12.4.e054697.15","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928"},{"key":"2025120518021172000_12.4.e054697.16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0037-1604471","article-title":"Preeclampsia: definitions of hypertensive states during pregnancy pathophysiological foundations","volume":"39","author":"Geraldo","year":"2017","journal-title":"Rev Bras Ginecol Obs"},{"key":"2025120518021172000_12.4.e054697.17","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2025120518021172000_12.4.e054697.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1089"},{"key":"2025120518021172000_12.4.e054697.19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.27"},{"key":"2025120518021172000_12.4.e054697.20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm324"},{"key":"2025120518021172000_12.4.e054697.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.942"},{"key":"2025120518021172000_12.4.e054697.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.016"},{"key":"2025120518021172000_12.4.e054697.23","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122969"},{"key":"2025120518021172000_12.4.e054697.24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.157297"},{"key":"2025120518021172000_12.4.e054697.25","doi-asserted-by":"publisher","DOI":"10.1038\/srep41926"},{"key":"2025120518021172000_12.4.e054697.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179159"},{"key":"2025120518021172000_12.4.e054697.27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurpub\/ckx148","article-title":"Maternal serum bisphenol A levels and risk of pre-eclampsia: a nested case-control study","volume":"27","author":"Ye","year":"2017","journal-title":"Eur J Public Health"},{"key":"2025120518021172000_12.4.e054697.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.120723","article-title":"Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia","volume":"3","author":"Gong","year":"2018","journal-title":"JCI Insight"},{"key":"2025120518021172000_12.4.e054697.29","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0308"},{"key":"2025120518021172000_12.4.e054697.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72852-4","article-title":"Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"2025120518021172000_12.4.e054697.31","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020043","article-title":"Per- and Polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: a case-control study in Southern Sweden","volume":"8","author":"Rylander","year":"2020","journal-title":"Toxics"},{"key":"2025120518021172000_12.4.e054697.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82804-1","article-title":"Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study","volume":"11","author":"Harville","year":"2021","journal-title":"Sci Rep"},{"key":"2025120518021172000_12.4.e054697.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232391"},{"key":"2025120518021172000_12.4.e054697.34","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.158238"},{"key":"2025120518021172000_12.4.e054697.35","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2822"},{"key":"2025120518021172000_12.4.e054697.36","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.130419"},{"key":"2025120518021172000_12.4.e054697.37","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105656","article-title":"Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study","volume":"138","author":"Huo","year":"2020","journal-title":"Environ Int"},{"key":"2025120518021172000_12.4.e054697.38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ije\/dyz098","article-title":"4-Hydroxyglutamate is a novel predictor of pre-eclampsia","volume":"49","author":"Sovio","year":"2020","journal-title":"Int J Epidemiol"},{"key":"2025120518021172000_12.4.e054697.39","article-title":"NMR profiling in early pregnancy reveals a metabolomic signature the predicts the subsequent development preeclampsia","volume":"20","author":"Kenny","year":"2013","journal-title":"Reprod Sci"},{"key":"2025120518021172000_12.4.e054697.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050963"},{"key":"2025120518021172000_12.4.e054697.41","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.179069"},{"key":"2025120518021172000_12.4.e054697.42","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.109"},{"key":"2025120518021172000_12.4.e054697.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098540"},{"key":"2025120518021172000_12.4.e054697.44","first-page":"541","article-title":"Is midtrimester vitamin D status associated with spontaneous preterm birth and preeclampsia?","volume":"31","author":"Wetta","year":"2014","journal-title":"Am J Perinatol"},{"key":"2025120518021172000_12.4.e054697.45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/AOG.0000000000001041","article-title":"Second-trimester maternal serum paraxanthine, CYP1A2 activity, and the risk of severe preeclampsia","volume":"126","author":"Eichelberger","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025120518021172000_12.4.e054697.46","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/857108","article-title":"First-Trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach","volume":"2015","author":"Koster","year":"2015","journal-title":"Dis Markers"},{"key":"2025120518021172000_12.4.e054697.47","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1289\/EHP188","article-title":"Urinary concentrations of bisphenol A and phthalate metabolites measured during pregnancy and risk of preeclampsia","volume":"124","author":"Cantonwine","year":"2016","journal-title":"Environ Health Perspect"},{"key":"2025120518021172000_12.4.e054697.48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.preghy.2013.01.001","article-title":"Early-pregnancy asymmetric dimethylarginine (ADMA) levels in women prone to develop recurrent hypertension","volume":"3","author":"Rijvers","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"2025120518021172000_12.4.e054697.49","doi-asserted-by":"publisher","DOI":"10.1021\/pr4002355"},{"key":"2025120518021172000_12.4.e054697.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.06.044"},{"key":"2025120518021172000_12.4.e054697.51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4314\/ahs.v16i1.5","article-title":"Vitamin D status in the first-trimester: effects of vitamin D deficiency on pregnancy outcomes","volume":"16","author":"Ates","year":"2016","journal-title":"Afr Health Sci"},{"key":"2025120518021172000_12.4.e054697.52","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/14767058.2016.1185411","article-title":"Metabolomic determination of pathogenesis of late-onset preeclampsia","volume":"30","author":"Bahado-Singh","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025120518021172000_12.4.e054697.53","doi-asserted-by":"crossref","first-page":"e4811","DOI":"10.1210\/clinem\/dgaa642","article-title":"The 15-Epilipoxin-A4 pathway with prophylactic aspirin in preventing preeclampsia: a longitudinal cohort study","volume":"105","author":"Shanmugalingam","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025120518021172000_12.4.e054697.54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.freeradbiomed.2015.05.012","article-title":"Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsia","volume":"85","author":"Bilodeau","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"2025120518021172000_12.4.e054697.55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.120723","article-title":"Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia","volume":"3","author":"Gong","year":"2018","journal-title":"JCI Insight"},{"key":"2025120518021172000_12.4.e054697.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031238"},{"key":"2025120518021172000_12.4.e054697.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.11.003"},{"key":"2025120518021172000_12.4.e054697.58","doi-asserted-by":"crossref","first-page":"66.e1","DOI":"10.1016\/j.ajog.2013.09.010","article-title":"Placental pathology suggesting that preeclampsia is more than one disease","volume":"210","author":"Nelson","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2025120518021172000_12.4.e054697.59","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040923"},{"key":"2025120518021172000_12.4.e054697.60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2020.105656","article-title":"Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study","volume":"138","author":"Huo","year":"2020","journal-title":"Environ Int"},{"key":"2025120518021172000_12.4.e054697.61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055352"},{"key":"2025120518021172000_12.4.e054697.62","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0646-8"},{"key":"2025120518021172000_12.4.e054697.63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2018.09.006","article-title":"Role of dyslipidemia in preeclampsia-A review of lipidomic analysis of blood, placenta, syncytiotrophoblast microvesicles and umbilical cord artery from women with preeclampsia","volume":"139","author":"Wojcik-Baszko","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2025120518021172000_12.4.e054697.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2009.01.003"},{"key":"2025120518021172000_12.4.e054697.65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction","volume":"3","author":"de Carvalho","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2025120518021172000_12.4.e054697.66","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P064451"},{"key":"2025120518021172000_12.4.e054697.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.08.020"},{"key":"2025120518021172000_12.4.e054697.68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0996"},{"key":"2025120518021172000_12.4.e054697.69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2017.09.009","article-title":"Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration","volume":"60","author":"Westwood","year":"2017","journal-title":"Placenta"},{"key":"2025120518021172000_12.4.e054697.70","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-14-1"},{"key":"2025120518021172000_12.4.e054697.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2004.12.011"},{"key":"2025120518021172000_12.4.e054697.72","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.242"},{"key":"2025120518021172000_12.4.e054697.73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-014-0468-2","article-title":"Blood pressure in relation to coffee and caffeine consumption","volume":"16","author":"Guessous","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"2025120518021172000_12.4.e054697.74","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.016667"},{"key":"2025120518021172000_12.4.e054697.75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FPC.0b013e3283602e75","article-title":"Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers","volume":"23","author":"Dobrinas","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"2025120518021172000_12.4.e054697.76","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-007-0081-3"},{"key":"2025120518021172000_12.4.e054697.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.08.009"},{"key":"2025120518021172000_12.4.e054697.78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:02:24Z","timestamp":1764986544000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":78,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,25]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-054697"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054697","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}